Drug intelligence / Profile preview

Yiqi Gubiao Pill (Humanwell Healthcare Group Co., Ltd.)

Development stage: Unknown
Lead developer: Humanwell Healthcare
Administration: Oral

Overview

Yiqi Gubiao Pill (益气固表丸) is a traditional Chinese medicine (TCM) developed by Wuhan Humanwell Hi-Tech Industry for the treatment of Chronic Obstructive Pulmonary Disease (COPD). It is specifically indicated for patients in the stable phase of COPD who exhibit the TCM syndrome of lung-spleen qi deficiency and phlegm-turbidity blocking the lungs. Formulated as an oral pill, the medication is designed to tonify qi, strengthen the body's exterior defenses, and resolve phlegm to improve respiratory symptoms and overall lung function. It is currently in Phase 2 clinical development in China.

Other names: 益气固表丸Yiqi Gubiao Wan

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)IL-6 (Interleukin 6)MAPK3 (Mitogen-activated protein kinase 1)

Beyond the preview

Go deeper on Yiqi Gubiao Pill (Humanwell Healthcare Group Co., Ltd.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yiqi Gubiao Pill (Humanwell Healthcare Group Co., Ltd.).

Explore the full profile